LEXARIA BIOSCIENCE ($LEXX) posted quarterly earnings results for Q2 2026 on Monday, April 13th. The company reported earnings of -$0.06 per share, beating estimates of -$0.10 by $0.04. The company also reported revenue of $20,000, missing estimates of $51,000 by $-31,000.
Stock price change since market open this morning: -2.38%
You can see Quiver Quantitative's $LEXX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LEXARIA BIOSCIENCE Hedge Fund Activity
We have seen 8 institutional investors add shares of LEXARIA BIOSCIENCE stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MURCHINSON LTD. removed 419,590 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $258,887
- UBS GROUP AG added 354,210 shares (+4995.9%) to their portfolio in Q4 2025, for an estimated $218,547
- BYRNE ASSET MANAGEMENT LLC removed 104,700 shares (-99.2%) from their portfolio in Q1 2026, for an estimated $81,666
- GEODE CAPITAL MANAGEMENT, LLC added 44,939 shares (+25.7%) to their portfolio in Q4 2025, for an estimated $27,727
- WEALTH ENHANCEMENT ADVISORY SERVICES, LLC removed 35,776 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $22,073
- VIRTU FINANCIAL LLC removed 29,360 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $18,115
- INVENOMIC CAPITAL MANAGEMENT LP removed 6,286 shares (-1.3%) from their portfolio in Q4 2025, for an estimated $3,878
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
